DashboardPortfoliosFavoritenGemeinschaftEntdeckenSuchen
NOT FOR DISTRIBUTION

Alpha Teknova, Inc.

NasdaqGM:TKNO Lagerbericht

Marktkapitalisierung: US$371.0m

  • Unternehmensüberblick
  • Bewertung
  • Ausblick und Wachstum
  • Leistungs-Rückblick
  • Finanzlage
  • Dividende
  • Management
  • Eigentümerschaft
  • Weitere Informationen
  • Aktien-Community

Alpha Teknova Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Die Gewinne von Alpha Teknova sind mit einer durchschnittlichen Jahresrate von -1.8% zurückgegangen, während die Gewinne der Branche Life Sciences um 4.3% pro Jahr zurückgingen. Die Umsätze sind gewachsen mit einer durchschnittlichen Jahresrate von 0.9%.

Wichtige Informationen

-1.81%

Wachstumsrate der Gewinne

16.28%

EPS-Wachstumsrate

Life Sciences Wachstum der Industrie21.51%
Wachstumsrate der Einnahmen0.94%
Eigenkapitalrendite-26.79%
Netto-Marge-38.37%
Letzte Ertragsaktualisierung30 Jun 2026

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

User avatar
Narrative-Update • Jun 25

TKNO: Reaffirmed 2026 Revenue Guidance Will Support Future Upside Potential

Analysts have adjusted their price target on Alpha Teknova to reflect updated assumptions around fair value at $7.00, a discount rate of 8.08%, revenue growth of 15.09%, a profit margin of 15.57%, and a future P/E of 47.22, citing these revised inputs as the key drivers of their refreshed outlook. What’s in the News for Alpha Teknova Alpha Teknova reaffirmed its revenue guidance for the fiscal year ending December 31, 2026, with expected total revenue in the range of $42 million to $44 million.
User avatar
Narrative-Update • Jun 05

TKNO: Confirmed 2026 Revenue Guidance Will Support Future Upside Potential

Analysts have slightly adjusted their price expectations for Alpha Teknova, with the updated target now reflecting modest shifts in the discount rate, forecast revenue growth, profit margins, and future P/E assumptions. Together, these factors point to a more finely tuned valuation in dollar terms.
Analyseartikel • May 09

Analyst Estimates: Here's What Brokers Think Of Alpha Teknova, Inc. (NASDAQ:TKNO) After Its First-Quarter Report

Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...
User avatar
Narrative-Update • Apr 28

TKNO: Long Term Revenue Guidance Will Support Future Upside Potential

Analysts have adjusted their price target on Alpha Teknova to $7.00 per share from $7.00, reflecting updated views on discount rates, revenue growth, profit margins, and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, with an expected total revenue range of $42 million to $44 million (company guidance).
User avatar
Narrative-Update • Apr 12

TKNO: Long Term Revenue Guidance And Higher P/E Will Support Future Upside

Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7.00, reflecting updated views on discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating an expected total revenue range of $42 million to $44 million.
User avatar
Narrative-Update • Mar 26

TKNO: Long Term Revenue Guidance Will Support Future Upside Potential

Analysts have adjusted their price target on Alpha Teknova to $7.00 from $7, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that leave their fair value view essentially unchanged. What's in the News Alpha Teknova issued revenue guidance for the fiscal year ending December 31, 2026, indicating expected total revenue in a range of $42 million to $44 million.
User avatar
Narrative-Update • Mar 11

TKNO: Updated Revenue Outlook Will Support Future Upside Potential

Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they factor in updated assumptions for the discount rate, revenue growth, profit margin and future P/E. Their view remains broadly aligned with prior estimates while they fine tune the model inputs.
User avatar
Narrative-Update • Feb 25

TKNO: Steady Fair Value Anchor Will Support Future Upside Potential

Analysts have trimmed their price target on Alpha Teknova to $7.00 from $7 as they adjust assumptions around discount rates, revenue growth, profit margins, and future P/E. This reflects updated views on the company’s risk profile and earnings potential.
User avatar
Narrative-Update • Feb 10

TKNO: Steady Fair Value Anchor Will Support Future Upside Potential

Narrative Update on Alpha Teknova Analysts have kept their fair value estimate for Alpha Teknova broadly steady at about $7.00. They explain that modest tweaks to assumptions, such as a slightly higher discount rate, small adjustments to revenue growth and profit margin outlooks, and a marginally lower future P/E, leave their overall price target view essentially unchanged.
User avatar
Narrative-Update • Jan 27

TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside

Analysts have nudged their price target on Alpha Teknova slightly higher, citing updated assumptions around discount rates, revenue growth of about 17.6% and a future P/E near 46.1x to support a modestly refined fair value estimate of about $7.00 per share. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with total revenue still expected in the range of $39 million to $42 million.
Analyseartikel • Jan 18

Alpha Teknova, Inc.'s (NASDAQ:TKNO) Share Price Is Still Matching Investor Opinion Despite 29% Slump

Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 29% in the last...
User avatar
Narrative-Update • Jan 13

TKNO: Earnings Guidance And Tuck In Deals Will Drive Future Upside

Analysts have modestly adjusted their price target on Alpha Teknova, citing an updated fair value of $7.00, a slightly higher discount rate, revised revenue growth expectations to 17.46%, a small change in the assumed profit margin, and a lower future P/E estimate of 46.25x. What's in the News Alpha Teknova reiterated earnings guidance for the fiscal year ending December 31, 2025, with expected total revenue in a range of $39 million to $42 million.
User avatar
Narrative-Update • Dec 27

TKNO: Earnings Guidance And Tuck In Deals Will Support Future Upside

Narrative Update: Alpha Teknova Analysts have modestly raised their price target on Alpha Teknova by approximately $1.00 per share, reflecting slightly higher assumptions for long term revenue growth and profit margins. This is partially offset by a marginally higher discount rate and a small reduction in projected future P E multiples.
User avatar
Narrative-Update • Dec 13

TKNO: Earnings Guidance And M&A Efforts Will Support Future Upside Potential

Analysts have trimmed their price target for Alpha Teknova from 8 dollars to 7 dollars, citing slightly slower expected revenue growth and a higher perceived discount rate, despite modestly better margin and valuation assumptions. What's in the News Reiterated 2025 earnings guidance, maintaining projected total revenue in the range of 39 million dollars to 42 million dollars for the year ending December 31, 2025 (company guidance).
Analyseartikel • Nov 12

Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.00

Alpha Teknova, Inc. ( NASDAQ:TKNO ) just released its quarterly report and things are looking bullish. Results overall...
Analyseartikel • Sep 25

Alpha Teknova, Inc.'s (NASDAQ:TKNO) P/S Is Still On The Mark Following 27% Share Price Bounce

Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have had a really impressive month, gaining 27% after a shaky period...
Analyseartikel • Jul 22

Alpha Teknova, Inc.'s (NASDAQ:TKNO) 26% Cheaper Price Remains In Tune With Revenues

To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 26% in the...
Analyseartikel • Jun 11

Shareholders Will Probably Not Have Any Issues With Alpha Teknova, Inc.'s (NASDAQ:TKNO) CEO Compensation

Key Insights Alpha Teknova will host its Annual General Meeting on 17th of June CEO Stephen Gunstream's total...
User avatar
Neues Narrative • Mar 29

Acquisitions And Collaborations Will Expand Cell And Gene Therapy Portfolio

Expansion through collaborations and acquisitions aims to boost top-line growth, margins, and financial stability amidst anticipated market rebound.
Analyseartikel • Mar 06

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets

Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders are probably feeling a little disappointed, since its shares fell 9.3...
Analyseartikel • Feb 28

Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing

Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders won't be pleased to see that the share price has had a very rough...
Analyseartikel • Feb 23

Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO)

Key Insights The projected fair value for Alpha Teknova is US$8.71 based on 2 Stage Free Cash Flow to Equity With...
Analyseartikel • Dec 14

Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 28%

Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 28% in...
Analyseartikel • Oct 15

Revenues Tell The Story For Alpha Teknova, Inc. (NASDAQ:TKNO) As Its Stock Soars 42%

Despite an already strong run, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares have been powering on, with a gain of 42% in...
Analyseartikel • Jun 27

Alpha Teknova, Inc. (NASDAQ:TKNO) Might Not Be As Mispriced As It Looks After Plunging 30%

Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...
Analyseartikel • Apr 24

Not Many Are Piling Into Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Yet As It Plummets 25%

To the annoyance of some shareholders, Alpha Teknova, Inc. ( NASDAQ:TKNO ) shares are down a considerable 25% in the...
Analyseartikel • Jan 22

Health Check: How Prudently Does Alpha Teknova (NASDAQ:TKNO) Use Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyseartikel • Aug 14

Some Analysts Just Cut Their Alpha Teknova, Inc. (NASDAQ:TKNO) Estimates

Market forces rained on the parade of Alpha Teknova, Inc. ( NASDAQ:TKNO ) shareholders today, when the analysts...
Analyseartikel • Apr 17

Take Care Before Jumping Onto Alpha Teknova, Inc. (NASDAQ:TKNO) Even Though It's 30% Cheaper

Unfortunately for some shareholders, the Alpha Teknova, Inc. ( NASDAQ:TKNO ) share price has dived 30% in the last...
Analyseartikel • May 14

Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported, And Analysts Assigned A US$23.00 Price Target

As you might know, Alpha Teknova, Inc. ( NASDAQ:TKNO ) just kicked off its latest quarterly results with some very...

Aufschlüsselung der Einnahmen und Ausgaben

Wie Alpha Teknova Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

NasdaqGM:TKNO Einnahmen, Ausgaben und Erträge (USD Millions)
DatumEinnahmenGewinnAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 2644-17272
31 Mar 2642-17272
31 Dec 2541-17272
30 Sep 2540-18272
30 Jun 2539-21272
31 Mar 2538-23272
31 Dec 2438-27283
30 Sep 2436-32293
30 Jun 2435-34314
31 Mar 2437-36325
31 Dec 2337-37336
30 Sep 2337-39356
30 Jun 2339-52367
31 Mar 2339-51387
31 Dec 2241-47378
30 Sep 2244-38367
30 Jun 2242-19337
31 Mar 2239-15286
31 Dec 2137-10244
30 Sep 2137-6203
30 Jun 2137-3162
31 Mar 21340132
31 Dec 20311102
31 Dec 1921-171

Qualität der Erträge: TKNO ist derzeit unrentabel.

Wachsende Gewinnspanne: TKNO ist derzeit unrentabel.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: TKNO ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 1.8% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von TKNO verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: TKNO ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Life Sciences (9.6%) erschwert.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: TKNO hat eine negative Eigenkapitalrendite (-26.79%), da es derzeit unrentabel ist.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/09/11 13:09
Aktienkurs zum Tagesende2026/09/11 00:00
Gewinne2026/06/30
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
  • SEC-Formular 10-K
  • SEC-Formular 10-Q
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
  • Analysten Research Berichte
  • Blue Matrix
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
  • ICE-Marktdaten
  • SEC-Formular S-1
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
  • SEC-Formular 4
  • SEC-Formular 13D
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
  • SEC-Formular 10-K
  • SEC-Formular DEF 14A
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens
  • SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Alpha Teknova, Inc. wird von 8 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Mark MassaroBTIG
Matthew HewittCraig-Hallum Capital Group LLC
Paul KnightKeyBanc Capital Markets Inc.

Triff überall bessere Investmententscheidungen

Zum Herunterladen scannen
App Store öffnenGoogle Play öffnen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Datenquellen anzeigen
Märkte
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideen für Investitionen
  • Unterbewertete Unternehmen
  • Dividendenstarke Unternehmen
  • Insider-Käufe
  • Kernenergie
  • Autonome Fahrzeuge
  • Künstliche Intelligenz
  • Kryptowährung und Blockchain
  • Cybersicherheit
  • Weitere Ideen
Börsengemeinschaften
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Werkzeuge und Funktionen
  • Portfolio-Tracker
  • Aktien-Screener & Alarme
  • Erzählungen & faire Werte
  • Dividenden-Rechner
Nachrichten & Entdeckungen
  • Neueste Bestandsnachrichten
  • Globale Markteinsichten
  • Der Fuchsbau
  • Ideen für Investitionen
  • Community-Erzählungen
  • Was gibt's Neues?
Simply Wall St
  • Pläne & Preisgestaltung
  • Werbung},{
  • Über uns
  • Kontakt
  • Karriere
  • Hilfe-Center
  • Lernen Sie das Investieren in Aktien
  • Partnerprogramm
  • Business & Unternehmen
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Bedingungen und Konditionen
  • Datenschutzbestimmungen
  • KI-Bedingungen
  • Leitfaden für Finanzdienstleistungen